Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100

Abbott Laboratories (ABT) Book value per share

Alert me on Book value per share

Abbott Laboratories's book value per share at the end of fiscal 2025 was 30.3×, up 10.1% from 27.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 29.7×. Over the past ten years it has ranged from 14.0× (fiscal 2016) to 30.3× (fiscal 2025) — the current reading is the highest in ten years. Abbott Laboratories ranks 14th of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 30.3× 10.10%
FY2024 27.5× 23.37%
FY2023 22.3× 5.99%
FY2022 21.1× 3.73%
FY2021 20.3× 9.03%
FY2020 18.6× 5.14%
FY2019 17.7× 1.31%
FY2018 17.5× (2.22%)
FY2017 17.9× 27.42%
FY2016 14.0× (1.61%)

Quarterly newest first

Period Book value per share Change
Jun 2026 29.7× (1.67%)
Mar 2026 30.2× (0.22%)
Dec 2025 30.3× 3.01%
Sep 2025 29.4× 0.93%
42 more quarters

Against its own ten years

Low 14.0× High 30.3×
Ten-year median 18.6×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on ABT